Clinico-pharmacological approach to rifampicin and isoniazid dosage
Karkishchenko, N.N.; Khoron'ko, V.V.; Vorob'ev, V.S.; Anisimova, N.B.; Chubarian, V.T.
Problemy Tuberkuleza 9: 31-34
1987
ISSN/ISBN: 0032-9533 PMID: 3422964 Document Number: 290598
Document emailed within 1 workday
Related Documents
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Marche, J.; Hugues, F.C.; Graisely, B.; Marche, C. 1971: Hepatitis induced by combination of rifampicin and isoniazid Annales de Medecine Interne 122(10): 1045-1054
Bonora, G.; De La Pierre, L.; Perletti, L. 1981: Hepatotoxicity of the rifampicin-isoniazid combination in children Minerva Pediatrica 33(16): 835-836
Skakun, N.P.; Tabachuk, O.E. 1991: Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol Problemy Tuberkuleza 1991(10): 77-79
Kasantikul, V. 1989: Isoniazid-rifampicin-induced submassive hepatic necrosis Journal of the Medical Association of Thailand 72(1): 56-58
Ramachandran, G.; Hemanth Kumar, A.K.; Srinivasan, R.; Geetharani, A.; Sugirda, P.; Nandhakumar, B.; Nandini, R.; Tharani, C.B. 2012: Effect of rifampicin and isoniazid on the steady state pharmacokinetics of moxifloxacin Indian Journal of Medical Research 136(6): 979-984
Nagayama, N.; Shishido, Y.; Masuda, K.; Baba, M.; Tamura, A.; Nagai, H.; Akagawa, S.; Kawabe, Y.; Machida, K.; Kurashima, A.; Komatsu, H.; Yotsumoto, H. 2004: Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid Kekkaku: 79(5): 341-348
Volosevich, G.V. 1989: Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis Problemy Tuberkuleza 9: 72-73
Lo Schiavo, A.; Cozzi, R.; Alfano, R.; Romano, F.; La Montagna, M.; Caccavale, T.; Capasso, R.; Mea, E.E.; Caccavale, S. 2014: A case of tuberculosis cutis colliquativa treated with rifampicin and isoniazid Acta Dermatovenerologica Croatica: Adc 22(2): 160-161
Freerksen, E.; Alvarenga, A.E.; Leguizamon, O.; de Morra, M.V.; von Ballestrem, W.; Reyes, L.A. 1991: Short-term chemotherapy of leprosy using the combination rifampicin + cotrimoxazole + isoniazid Medizinische Klinik 86(9): 441-448
Engbaek, H.C.; Larsen, S.O.; Rasmussen, K.N.; Vergmann, B. 1973: Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin Scandinavian Journal of Respiratory Diseases 54(2): 83-91
Zwolska, Z.; Augustynowicz-Kopeć, E.; Niemirowska-Mikulska, H. 2002: The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule Acta Poloniae Pharmaceutica 59(6): 448-452
Gendrel, D.; Nardou, M.; Mouba, J.F.; Gahouma, D.; Moussavou, A.; Boguikouma, J.B. 1989: Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus Archives Francaises de Pediatrie 46(9): 645-648
Murgoci, G. 1989: Coma--accidental poisoning occurring in the isoniazid + rifampicin treatment of a 7-year-old child Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 38(2): 149-156
Polasa, K.; Krishnaswamy, K. 1987: Effect of rifampicin induced S9 fraction on the mutagenicity of isoniazid in the Salmonella assay system Indian Journal of Medical Research 86: 232-236
Tayal, V.; Kalra, B.S.; Agarwal, S.; Khurana, N.; Gupta, U. 2007: Hepatoprotective effect of tocopherol against isoniazid and rifampicin induced hepatotoxicity in albino rabbits Indian Journal of Experimental Biology 45(12): 1031-1036
Hinaut, G.; Bosio, A.M.; Estampes, B. 1970: Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide Revue de Tuberculose et de Pneumologie 34(2): 291-295
Almansa de Cara, S. 1972: Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid) Revista Clinica Espanola 125(4): 353-356
Coury, C.; Constans, P.; Parrot, R.; Baron, A. 1970: Results of treatment with rifampicin-isoniazid in 100 tubercular patients with sensitive bacilli a 6 to 24 month controlled experiment Revue de Tuberculose et de Pneumologie 34(5): 688-697